Table 1 |
|||
|
Classification of hemophagocytic lymphohistiocytosis |
|||
|
Gene |
Protein |
Function |
|
|
|
|||
|
Genetic defects ('primary') |
|||
|
FHL1 |
Unknown (location 9q21.3-22) |
||
|
FHL2 |
PFR1 |
Perforin |
Pore-forming protein |
|
FHL3 |
UNC13D |
Munc13-4 |
Vesicle priming |
|
FHL4 |
STX11 |
Syntaxin-11 |
Vesicle transport and fusion |
|
FHL5 |
STXBP2 |
Munc18-2 |
Interacts with syntaxin-11 for vesicle transport and fusion |
|
Immunodeficiency syndromes associated with albinism |
|||
|
Chédiak Higashi syndrome |
LYST |
LYST |
Probably important for size and function of lytic granules |
|
Griscelli syndrome type II |
Rab27A |
Rab27A |
Vesicle docking/granule movement |
|
Hermansky-Pudlak syndrome type II |
AP3B1 |
Vesicle biogenesis, protein sorting |
|
|
Other primary immunodeficiencies |
|||
|
X-linked lymphoproliferative disorder type I |
SH2D1A |
SAP |
Signal transduction and activation of lymphocytes |
|
X-linked lymphoproliferative disorder type II |
BIRC4 |
XIAP |
Inhibition of apoptosis |
|
ITK deficiency |
ITK |
ITK |
T-cell kinase |
|
Other diseases associated with HLH ('secondary') |
Examples |
||
|
Infections |
EBV, leishmania |
||
|
Macrophage activation syndrome |
Still's disease, SLE |
||
|
Autoinflammatory |
|||
|
Malignancy |
T cell lymphoma |
||
|
Immunosuppression |
Post organ |
||
|
transplantation |
|||
|
Metabolic disease |
Lysinuric protein |
||
|
intolerance |
|||
|
Post-HSCT |
|||
|
|
|||
|
EBV, Epstein-Barr virus; FHL, familial hemophagocytic lymphohistiocytosis; HLH, hemophagocytic lymphohistiocytosis; HSCT, hematopoetic stem cell transplantation; ITK, IL-2 inducible T-cell kinase; SLE, systemic lupus erythematosus. Adapted from [1,20,49,87]. |
|||
|
Bode et al. Arthritis Research & Therapy 2012 14:213 doi:10.1186/ar3843 |
|||